Lataa...
Effects of obesity and 10 weeks metformin treatment on liver steatosis
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease in adolescents and adults, and the risk of developing NAFLD increases with obesity. In the present study, it was shown that obesity increased fatty liver (steatosis) using an obese Zucker rat model. Metformin is an oral...
Tallennettuna:
| Julkaisussa: | Biomed Rep |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8042663/ https://ncbi.nlm.nih.gov/pubmed/33859820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2021.1425 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|